Detalhe da pesquisa
1.
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
N Engl J Med
; 385(21): 1941-1950, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706189
2.
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 327(13): 1236-1246, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285853
3.
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).
Clin Infect Dis
; 73(7): e1507-e1517, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897367
4.
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.
Open Forum Infect Dis
; 10(8): ofad354, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577112
5.
Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19: A Randomized Clinical Trial.
JAMA Intern Med
; 182(1): 42-49, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807241